Search Tag: heart failure
Machine-learning-predicts-poor-diuretic-response-in-acute-decompensated-heart-failure
2024 07 Feb
A new study has paved the way for a groundbreaking approach to identifying patients with acute decompensated heart failure (ADHF) who may have a poor response to diuretic therapy. Published in the Journal of the American College of Cardiology, Heart Failure , the research introduces a machine learning-based phenomapping method and diuresis score...Read more
Machine-learning-predicts-poor-diuretic-response-in-acute-decompensated-heart-failure
2024 07 Feb
A new study has paved the way for a groundbreaking approach to identifying patients with acute decompensated heart failure (ADHF) who may have a poor response to diuretic therapy. Published in the Journal of the American College of Cardiology, Heart Failure , the research introduces a machine learning-based phenomapping method and diuresis score...Read more
Machine-learning-predicts-poor-diuretic-response-in-acute-decompensated-heart-failure
2024 07 Feb
A new study has paved the way for a groundbreaking approach to identifying patients with acute decompensated heart failure (ADHF) who may have a poor response to diuretic therapy. Published in the Journal of the American College of Cardiology, Heart Failure , the research introduces a machine learning-based phenomapping method and diuresis score...Read more
Most-people-do-not-know-the-impact-of-heart-disease
2024 30 Jan
Over half of the U.S. population (51%) remains unaware that heart disease is the leading cause of death, as per a recent Harris Poll survey conducted by the American Heart Association. This lack of awareness persists despite heart disease maintaining its status as the number one killer for over a century. Heart Disease and Stroke Statistics report...Read more
Michelle-bloom-md-named-system-director-of-cardio-oncology-at-nyu-langone-health
2023 13 Dec
A renowned expert in cardio-oncology and heart failure, Michelle Bloom, MD, has joined NYU Langone Health as system director of the Cardio-Oncology Program, which provides specialized care to protect patients’ heart health throughout cancer treatment and survivorship. Dr. Bloom is a professor in the Department of Medicine and a member of the Division...Read more
Agamon-health-partners-with-mayo-clinic-to-bridge-cardiology-gaps-using-ai-know-how
2023 07 Nov
Agamon Health's Patient Adherence platform is aimed at raising standards of cardiovascular care Agamon Health is a healthcare technology company that uses Generative AI and workflow automation to close gaps in patient care. In collaboration with Mayo Clinic through a know-how agreement, Agamon Health aims to extend its offering to cardiology....Read more
Esccongress2023-chinese-medicine-shows-heart-failure-benefit
2023 26 Aug
Late-breaking research presented at ESC Congress 2023 reveals that qiliqiangxin, a traditional Chinese medicine, effectively reduces hospitalisations due to heart failure and cardiovascular-related deaths among patients suffering from heart failure and reduced ejection fraction (HFrEF). Derived from a blend of 11 distinct herbs, qiliqiangxin...Read more
Esccongress2023-semaglutide-improves-heart-failure-related-symptoms-physical-function
2023 25 Aug
In recent breakthrough research presented during a Hot Line session at ESC Congress 2023, semaglutide's effectiveness in improving symptoms and physical function related to heart failure and inducing greater weight loss was reported. Nearly 50% of heart failure patients are affected by heart failure with preserved ejection fraction (HFpEF)....Read more
Heart-failure-patients-can-step-their-way-to-better-health
2023 01 Aug
A recent study reports that individuals with heart failure who increased their daily step count experienced notable improvements in their health status during a 12-week period. Consumer wearable devices to track health status and progress have become increasingly popular. However, interpreting data from these devices, including step count,...Read more
Personalised-treatment-for-heart-failure
2023 28 Jun
The AI4HF project was recently launched in Utrecht, the Netherlands. The project is designed to pioneer the development of the first reliable artificial intelligence (AI) model for managing heart failure patients. The initiative is led by a consortium of global partners, including the European Society of Cardiology (ESC). Professor Folkert Asselbergs,...Read more
Which-vasopressors-and-inotropes-to-use-in-the-intensive-care-unit
2023 20 Apr
Vasopressors and inotropes are frequently used in intensive care units. With a special focus on recent studies, this article summarises the key messages in the management of patients requiring inotropes and vasopressors. Introduction Cardiac output (CO) is a key determinant of oxygen delivery. Low cardiac output syndrome (LCOS) causes...Read more
Global-summit-on-cardiology-and-cardio-care
2023 30 Nov
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find Scientex Conferences On Social Media</b> </font></h2><div style="text-align: center;"> <a href=https://twitter.com/scientexevents target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=85 hRead more
Short-acting-beta-blockers-in-critically-ill-patients-with-heart-failure
2022 14 Oct
An overview of the clinical evidence demonstrating the effectiveness of landiolol for the treatment of atrial fibrillation or atrial flutter with heart failure and effective heart rate control during arrhythmias. Supraventricular arrhythmias (SVTs) are common in post-operative and cardiac ICUs. SVTs increase the risk of death...Read more
Short-acting-beta-blockers-in-critically-ill-patients-with-heart-failure
2022 14 Oct
An overview of the clinical evidence demonstrating the effectiveness of landiolol for the treatment of atrial fibrillation or atrial flutter with heart failure and effective heart rate control during arrhythmias. Supraventricular arrhythmias (SVTs) are common in post-operative and cardiac ICUs. SVTs increase the risk of death...Read more
Heart-failure-2023
2023 20 May
Prague & Online Find European Society of Cardiology on Social Media Read more
Worsening-heart-disease-because-of-global-warming
2022 27 Sep
A new study reports that during the 2019 heatwave, hot temperatures were linked with weight loss in heart failure patients, indicating a worsening of their condition. The study is published in ESC Heart Failure. This is the first study to show a relationship between ambient temperature and body weight in heart failure patients. The weight loss...Read more
Speech-analysis-app-predicts-worsening-heart-failure
2022 24 May
A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The research was presented at Heart Failure 2022. In patients with heart failure, the heart does not pump blood around the body as well as it should. As a result, fluid...Read more
Estimated-plasma-volume-epv-in-critical-care
2022 28 Apr
Speakers Thomas Metkus, MD Divisions of Cardiology and Cardiac Surgery, Departments of Medicine and Surgery Johns Hopkins University School of Medicine Dennis Begos, MD, FACS, FACRS Medical Director, Medical and Scientific Affairs...Read more
Heart-failure-2022
2022 21 May
Madrid & Online Find European Society of Cardiology on Social Media Read more
Iron-deficiency-and-heart-disease
2021 12 Oct
Findings from a new study published in ESC Heart Failure show that around 10% of new coronary heart disease cases occurring within a decade of middle age could be avoided by preventing iron deficiency. While the study does not conclude that iron deficiency causes heart disease, it provides further evidence that there is a link between the two and...Read more
Esccongress-results-of-the-emperor-preserved-trial
2021 27 Aug
In a Hot Line Session at the ESC Congress 2021, the results of the EMPEROR-Preserved trial were presented that demonstrated a significant reduction in composite cardiovascular endpoints in patients with heart failure and preserved ejection fraction. This was a pooled analysis of two randomised trials that investigated the beneficial effects of...Read more